High tumour cannabinoid CB1 receptor immunoreactivity negatively impacts disease-specific survival in stage II microsatellite stable colorectal cancer.
<h4>Background</h4>There is good evidence in the literature that the cannabinoid system is disturbed in colorectal cancer. In the present study, we have investigated whether CB(1) receptor immunoreactive intensity (CB(1)IR intensity) is associated with disease severity and outcome.<h4...
Enregistré dans:
Auteurs principaux: | Sofia B Gustafsson, Richard Palmqvist, Maria L Henriksson, Anna M Dahlin, Sofia Edin, Stig O P Jacobsson, Åke Öberg, Christopher J Fowler |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2f94b9e5d28d4124b610b54a3ffed347 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer.
par: Sofia Edin, et autres
Publié: (2012) -
Cholesterol as a modulator of cannabinoid receptor CB2 signaling
par: Alexei Yeliseev, et autres
Publié: (2021) -
Circuit specific functions of cannabinoid CB1 receptor in the balance of investigatory drive and exploration.
par: Martin Häring, et autres
Publié: (2011) -
Comparison of Clinical and Histopathological Parameters amongst Microsatellite Unstable and Microsatellite Stable Cases of Colorectal Carcinomas in an Indian Setting
par: Divya Shelly, et autres
Publié: (2021) -
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
par: Marjolein Soethoudt, et autres
Publié: (2017)